FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys for patients with end-stage renal disease. Study aims to provide alternative for 500,000 Americans on dialysis.

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for more than two years.

A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time successfully transplanted a genetically edited pig kidney into a living person. The team performed the first surgery of its kind in the world in March 2024.

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig kidney into a living person.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.

Massachusetts General Hospital has transplanted a genetically edited pig kidney into a human for the second time.

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a small pilot study of a highly experimental treatment.

Two biotechnology companies will begin testing the procedures in patients suffering from kidney failure Sarah Kuta Daily Correspondent Doctors at NYU Langone Health recently performed a transplant surgery using a gene-edited pig kidney.